In addition, we assessed the clinical relevance of midnolin expression in four independent HCC patient cohorts (Korea, Modena, University of Hong Kong (UHK), and The Cancer Genome Atlas (TCGA)) [12,13,14] (Figure 2). The gene discussed is MIDN; the disease is hepatocellular carcinoma.